Distal anastomotic lesions after coronary artery bypass surgery: incidence, pathogenesis, and treatment approach

Salem Badr1, Danny Dvir, Ron Waksman

  • 1Interventional Cardiology, MedStar Washington Hospital Center, Washington Hospital Center, Washington, District of Columbia 20010, USA.

Insights

Distal anastomotic lesions frequently cause graft failure after coronary artery bypass surgery. Percutaneous coronary intervention is a viable alternative, but optimal treatment methods for these lesions remain under investigation.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Distal anastomotic lesions are the primary cause of venous and arterial bypass graft failure.
  • Redo coronary artery bypass surgery presents increased risks, including mortality and myocardial infarction.
  • Percutaneous coronary intervention (PCI) is considered for angina relief in patients with anastomotic lesions.

Purpose of the Study:

  • To review the incidence, pathogenesis, and treatment of distal anastomotic lesions in coronary bypass grafts.
  • To explore percutaneous coronary intervention as an alternative to repeat surgery.
  • To address the ongoing controversy regarding the optimal percutaneous treatment strategy.

Main Methods:

  • Review of reported data on distal anastomotic lesions.
  • Analysis of incidence and pathogenesis.
  • Evaluation of treatment options, including percutaneous interventions.

Main Results:

  • Distal anastomotic lesions are a common cause of graft failure.
  • PCI is a recognized alternative for symptom management.
  • Optimal percutaneous treatment approaches are still debated.

Conclusions:

  • Distal anastomotic lesions significantly impact graft patency and patient outcomes.
  • Percutaneous intervention offers a less invasive option for managing these lesions.
  • Further research is needed to establish the best percutaneous treatment strategies.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...